AU8976598A - Budipine in the treatment of inflammatory disorders of the nervous system - Google Patents

Budipine in the treatment of inflammatory disorders of the nervous system

Info

Publication number
AU8976598A
AU8976598A AU89765/98A AU8976598A AU8976598A AU 8976598 A AU8976598 A AU 8976598A AU 89765/98 A AU89765/98 A AU 89765/98A AU 8976598 A AU8976598 A AU 8976598A AU 8976598 A AU8976598 A AU 8976598A
Authority
AU
Australia
Prior art keywords
budipine
treatment
nervous system
inflammatory disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU89765/98A
Inventor
Reijko Kruger
Wilfried Kuhn
Thomas Muller
Horst Przuntek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of AU8976598A publication Critical patent/AU8976598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU89765/98A 1997-07-23 1998-07-17 Budipine in the treatment of inflammatory disorders of the nervous system Abandoned AU8976598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19731521 1997-07-23
DE1997131521 DE19731521A1 (en) 1997-07-23 1997-07-23 Budipin in the treatment of inflammatory diseases of the nervous system
PCT/EP1998/004457 WO1999004793A2 (en) 1997-07-23 1998-07-17 Budipine in the treatment of inflammatory disorders of the nervous system

Publications (1)

Publication Number Publication Date
AU8976598A true AU8976598A (en) 1999-02-16

Family

ID=7836555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89765/98A Abandoned AU8976598A (en) 1997-07-23 1998-07-17 Budipine in the treatment of inflammatory disorders of the nervous system

Country Status (3)

Country Link
AU (1) AU8976598A (en)
DE (1) DE19731521A1 (en)
WO (1) WO1999004793A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
US7364736B2 (en) 2001-06-26 2008-04-29 Amgen Inc. Antibodies to OPGL

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11503140A (en) * 1995-04-05 1999-03-23 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated diseases

Also Published As

Publication number Publication date
WO1999004793A3 (en) 1999-04-08
DE19731521A1 (en) 1999-01-28
WO1999004793A2 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
AU6396598A (en) Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders
EP1143956A3 (en) Compositions and methods for the treatment of anorectal disorders
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU8769098A (en) System for treating patients with anxiety disorders
AUPM864894A0 (en) Treatment of bowel-dependent neurological disorders
AUPO203996A0 (en) Therapeutic uses
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
AU7132998A (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
EP1063990A4 (en) Therapy of estrogen-associated disorders
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU2058697A (en) Treatment of sleep disorders
AU2325999A (en) Methods of neuroendocrine regulation of affective disorders
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU2418499A (en) Org-5222 in the treatment of depression
PL332313A1 (en) Application of benzopyranoles in treatment of neurological disorders
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU4876997A (en) Treatment of iron overload disorders
AU1853397A (en) Treatment of pulmonary inflammation
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders
AU8976598A (en) Budipine in the treatment of inflammatory disorders of the nervous system
AU1282099A (en) Method for treatment of disorders of attention

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase